The Ozempic Age: How a Drug Remade America

Every Sunday night, millions of Americans perform the same private ritual: uncapping a small pen injector, finding a spot on the abdomen or thigh, pressing a button. No one announces it at the dinner table. No one posts about it — at least, not under their real name. And yet, in under three years, this quiet weekly act has become the most consequential medical behavior change in a generation, reshaping not just waistlines but the entire architecture of American life. In The Ozempic Age, journalist Sarah Mitchell delivers the first comprehensive cultural history of the GLP-1 revolution — a story that is simultaneously about a molecule discovered in Gila monster saliva, a $1,000-a-month class divide that makes the drug accessible to some and invisible to others, a food industry in existential panic, a body-positivity movement cracking under pressure, and a profound philosophical question: what happens to concepts like willpower, identity, and the self when a weekly injection can silence the voice in your head that never stopped thinking about food? Drawing on interviews with scientists, patients, economists, eating disorder specialists, and the quietly injecting millions, Mitchell traces how Ozempic moved from a diabetes medication nobody had heard of to a cultural lightning rod that exposed every fault line in American society — about bodies, class, desire, discipline, and what we owe each other. Neither a celebration nor a moral panic, The Ozempic Age is the book America needs to understand the moment it is living through. Propulsive, rigorously reported, and impossible to put down, it holds open the question that no one else has been brave enough to ask: Is this the greatest public health advance since vaccines — or have we just decided, as a nation, that the human appetite itself is a problem to be solved?